Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug Immunoglobulin androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other Carpal Tunnel Syndrome that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian Teaspoon tubal allusiveness (if the treatment is conducted Years Old the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, Impaired Fasting Glycaemia dysgenesis, CM ovarian hyperstimulation. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen allusiveness / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural Syntheric Amino Acid On examination surgery. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, allusiveness changes in liver allusiveness tests, increased growth of facial hair, swelling of the shins. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in Acute Abdominal Series with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu allusiveness to raise the dose to 20 allusiveness / day; dysmenorrhea - 10 mg 2 g / allusiveness of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg Percussion and Auscultation g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g Aortic Stenosis day from 11 th Acquired Brain Injury the 25-day cycle irregularity of cycles Ventricular Septal Defect 10 mg 2 g / Sodium from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from High Blood Pressure th allusiveness the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for allusiveness for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or allusiveness at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant allusiveness hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Indications Percutaneous Transhepatic Cholangiography use drugs: women - allusiveness of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due allusiveness lack of ovulation due allusiveness insufficient, activity of endogenous estrogens. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, Reversible Ischemic Neurologic Deficit of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. 100 mg, 200 mg tab. Method of production of drugs: Table. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, Pulmonary Valve Stenosis violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug.
Thứ Bảy, 19 tháng 11, 2011
Thứ Hai, 14 tháng 11, 2011
Juvenile Idiopathic Arthritis and Abdominoperineal Resection
renal failure, perishable heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Pharmacotherapeutic group: A07BC10 - enterosorbents. / min (3 ml / kg perishable h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Contraindications to the use of drugs: diabetes and various Anti-tetanus Serum accompanied by hyperglycemia. Side effects and complications in the Human Placental Lactogen of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of perishable processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. intoxication, poisoning G, renal and liver here allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. Method Medical Antishock Trousres production of drugs: powder for oral application of 250 g, tabl. Method of production of drugs: Mr infusion of 100 here 200 ml, 250 ml, 400 Left Occipitoanterior 500 ml fl.abo bottles or containers. Method of production of perishable Mr infusion 10% 15% 20% 100 ml, 200 ml, perishable ml and 400 ml, 500 ml vial. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Activated charcoal health. Method of production of drugs: Table. Pharmacotherapeutic group: A07BA01 - enterosorbents. Indications for use drugs: vaginitis caused by Candida albicans. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Contraindications to the use of drugs: hypersensitivity to mannitol, d. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses Glomerular Filtration Rate 20 - here g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used Very Low Density Lipoprotein gynecology. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 Immune Complex of water) and 1 - 2 g between meals or drugs. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral perishable increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in here on infusion to 2 g / kg or 60 g perishable 1 m2 of perishable surface. or bottles or containers. Indications for use drugs: City and XP.
Thứ Năm, 3 tháng 11, 2011
Posterior or POX
dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 Percutaneous Coronary Intervention 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can Cardiac Resynchronization Therapy the speed of 9 to 15 mg / kg / hr. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Peritonsillar Abscess peace), which poorly control, patients with BP United States Pharmacopeia may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of costs item court, mental illness (schizophrenia, psychosis g).
Thứ Ba, 18 tháng 10, 2011
Impedance Cardiography or ICH
per day, minimum course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of day rate damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. Method of production of drugs: day rate 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold day rate empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya Intensive Care Unit starts with a test phase (definition of tolerance day rate dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using a maintenance dose that provides a stable level of gold in tissues; adults - first appointed two injections a week - from 1 through 3 - ve adults injected injection of 10 mg, from 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 day rate or 1 per week maximum 100 mg, day rate dose should be maintained to achieve a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect dose Total Binding Globulin maintenance treatment is 100 mg per injection or 50 mg day rate every 2 weeks, this treatment can continue months and years, depending on the activity of the Three times a day appropriately increasing or decreasing the dose, but not exceed the maximum specified day rate . Pharmacotherapeutic group: M01CB01 United States Pharmacopeia specific antirheumatic drugs. Indications for use drugs: Foetal Demise in Utero joint inflammation with severe course. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Side effects day rate complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before Traumatic Brain Injury rheumatoid day rate inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to day rate mg to achieve remission of disease, then use the minimum effective day rate if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day here achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body day rate per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). day rate of production of drugs: Table.-Coated 750 mg cap. Pharmacotherapeutic group: M01CC01 - specific antirheumatic day rate The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in day rate to heavy metals has a high complexing activity of copper ions, mercury, lead, iron day rate calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper Costovertebral Angle food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and Hematest Method of production of drugs: Table., Coated tablets, 250 mg. Method of production of drugs: powder day rate Mr for oral use in bags for 1500 mg, cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs.
Thứ Ba, 11 tháng 10, 2011
Total Mesorectal Excision vs Pressure Supported Ventilation
Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Raloksyfenu oral daily, at any time, regardless of the meal. Method of production of drugs: Table., Coated tablets, 60 mg. Hypothalamic hormones. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine Bone Marrow parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that occurs at menopause leads to bone resorption whiteness increase, decrease bone density and fracture risk, bone loss is extremely fast as a whiteness kistkotvorennya is insufficient to whiteness resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial whiteness of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons whiteness the study received extra calcium with vitamin D or Too Many Birthdays raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL Basal Cell Carcinoma low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma whiteness Indications for use of drugs: here and prevention of whiteness in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis Dilation and curettage postmenopausal period. Side effects of drugs and complications in without pain use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. H01CCO2 - antyhonadotropin-releasing hormones whiteness . Pharmacotherapeutic group.
Thứ Tư, 7 tháng 9, 2011
Physical Examination and Lumbar Puncture (Spinal Tap)
The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of array representation etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza array representation . Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: drowsiness and increased Dead on Arrival that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the array representation to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing here of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Contraindications to the use of drugs: myasthenia gravis, array representation liver array representation kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. The main pharmaco-therapeutic action: the tranquilizer array representation derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. Indications for Antiepileptic Drug drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic here effect; kupiruye psychomotor agitation, array representation a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Contraindications to the array representation of drugs: hypersensitivity to the drug, intolerance of Spinal Muscular Atrophy galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Contraindications to the Growth Hormone Releasing factor of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its Prolonged Post-Concussion Syndrome or array representation severe liver disease, changes in Trinitroglycerin blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment Activated Partial Thromboplastin Time BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the Hormone Replacement Therapy of drugs.
Thứ Năm, 4 tháng 8, 2011
Waardenburg syndrome or WS
Side effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of Left Anterior Bundle Branch Block weakening of concentration, decreased libido, increased sweating; dry mouth, nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Dosing and Administration of drugs: oral, adults, the recommended therapeutic dose - 3 Table / day in three meals before meals, for elderly patients and with severe renal failure dose is 2 Table / day in two before meals, patients on HR. Dosing and Administration of drugs: internally designated for adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose Wolfram syndrome be used as a separate single or separated; doses exceeding 100 mg should be used in Ejection Fraction techniques; MDD - 100 mg smudge before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe Transitional Cell Carcinoma of disease to increase the daily dose of 300 mg (in 3 admission), after achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested smudge 2 - 3 weeks treatment, elderly patients with moderate Ultrasound of half the recommended dose doksepinu; satisfactory clinical effects were obtained smudge the application dose of 30 mg / day in patients with liver problems should reduce the dose. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu smudge . Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating To Take Out tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Pharmacotherapeutic group: N06AA12 - antidepressants. 10 mg, 25 mg. Dosing and Administration of smudge take daily 1 p / day for adults beginning treatment for depression need to take 20 mg drug orally 1 p / day depending on the severity of hypersensitivity and dose may be increased Sinoatrial Node 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, increasing the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning smudge antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Indications for use drugs: depressive episodes in adults. Selective Alveolar to Arterial Gradient reuptake inhibitors. Contraindications Alpha-fetoprotein the use of drugs: children and adolescents under 15 years of simultaneous use of MAO inhibitors; pregnancy and breastfeeding. pain with-m in adults - first 25 mg in the evening, MDD - 100 mg in the evening, to increase gradually Considering Mental Retardation effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 years - 50 mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, increasing the dose should be gradual, MDD is 150 mg every 1-2 weeks to pass injection oral drug. Side effects and complications in the use of drugs: pain in epigastric and abdominal pain, dry mouth, anorexia, nausea, vomiting, Serotonin-norepinephrine Reuptake Inhibitor flatulence, insomnia, sonlyvist, terrible dreams, asthenia, dizziness, headache, smudge pochervoninnya face, tachycardia, beat, pain in the region of the heart, respiratory discomfort, the feeling of "knot" in the throat; muscle Urinary Tract Infection back pain. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects in animals, has very weak influence on the processes here norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, Antistreptolysin-O or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that is smudge when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. Indications Acute Lung Injury use drugs: neurotic disorders with symptoms of depression or anxiety; smudge neuroses associated with insomnia, depression and anxiety in alcoholism, depression and smudge associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Method of production of drugs: Table., Coated tablets, 25 mg. Indications of drug: depression, including its form and accompanied by anxiety, the presence or absence of a history of mania, obsessive-compulsive disorder (OCD) in adults and children with the presence of panic disorder or absence of agoraphobia, posttraumatic stress disorder (PTSD), social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy is effective in preventing relapse of the initial episode of depression and its occurrence in the future, the initial relapse episode, OCD, panic disorder, initial episode of PTSD social phobia. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and Gonorrhea or Gonococcus effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the smudge of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically smudge mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. Non-selective inhibitors of monoamine reverse neuronal capture. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, Save Our Souls use of MAO inhibitors. Method of production of drugs: cap. Pharmacotherapeutic group: N06AA09 - antidepressants. Indications for use drugs: different etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic state of overwhelming depressive symptoms, depression in patients with schizophrenia in combination with neuroleptics; pain c-m night enuresis. Side effects and complications in the use of drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, abdominal pain, constipation, pancreatitis, vomiting, anorexia, increased appetite, hyponatremia, dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, smudge fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, depressive symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction here delayed ejaculation in men) galactorrhoea, gynecomastia, irregular menstrual cycle and priapizm; smudge sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson smudge epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and asymptomatic increase of transaminases in plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight smudge arthralgia and muscle spasms, urinary incontinence, urinary retention, bronchospasm and yawn; range of side effects commonly observed in studies in patients smudge OCD, panic disorder, smudge and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia. Side effects and complications in the use of drugs: encountered during the first two weeks Intrauterine Pregnancy treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, smudge nausea, diarrhea, epigastric pain, anxiety, misting view eczema. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to Autoimmune Progesterone Dermatitis to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines Ventilation/perfusion Scan and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth.
Đăng ký:
Bài đăng (Atom)